Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASP.L Regulatory News (ASP)

  • There is currently no data for ASP

AGM Statement

1 Nov 2006 13:04

Ascribe plc01 November 2006 Press Release 1 November 2006 Ascribe plc ('Ascribe' or 'the Group') AGM Statement Ascribe plc ("AIM:ASP"), the health IT Group, announces that at the Group'sAnnual General Meeting held today in Bolton, Lancashire, all resolutions put toShareholders by the Board were duly passed. At the meeting, the board of Ascribe also updated shareholders on the Group'sperformance since its Preliminary Results statement, as issued on Tuesday 12September for the period ending 30 June 2006. Speaking at the meeting, Stephen Critchlow, Executive Chairman, said: "I amdelighted to report that the Group has made a positive start to the 2006/7financial year, with trading performance in the first quarter being in line withmanagement expectations. Ascribe's core businesses continue to win market shareand, although the timing of new contract wins has recently been harder topredict, the resulting orders are larger than anticipated. "With Chris Dickson now on board as Chief Operating Officer, we are completingthe consolidation of the business with a particular focus on achieving acoordinated development plan. Integrating our operations and product to providea broad interoperable solution puts us in an ideal position to pick up businessfrom those Trusts that were previously expecting deliveries from the NationalProgramme for IT (NPfIT). Achieving this consolidation will also pave the way tobolt on selective and appropriate acquisitions in some key clinical areas. "I am especially pleased that cross-selling opportunities from recentacquisitions Barwick Systems, Jade Healthcare and HE Information Systems arealready contributing significantly to Ascribe's growth. "The Directors remain confident for the year as a whole as these acquisitionsplay an even greater role and the Group continues to deliver across the completeHealth IT market, independently of ongoing issues within NPfIT." - ends - For further information please contact: Ascribe plc Stephen Critchlow, Executive Chairman Tel: : +44 (0) 161 280 8080stephen.critchlow@ascribe.com www.ascribe.com Jeremy Lee, Finance Director Tel: : +44 (0) 161 280 8080jeremy.lee@ascribe.com www.ascribe.com Media enquiries: Abchurch Communications Stephanie Cuthbert / Justin Heath Tel: +44 (0) 20 7398 7700stephanie.cuthbert@abchurch-group.com www.abchurch-group.com About Ascribe plc: Ascribe plc is a leading healthcare company that develops and markets softwaresolutions supporting patient, clinical and business processes to Primary &Secondary healthcare providers on three continents with a range of integratedclinical IT solutions that service the needs of the patient as the ultimatecustomer. Our mission is to improve patient safety through the introduction oftechnologies that enhance communications, provide clinicians with patient dataand decision support systems and ultimately to reduce risks in healthcaremanagement and delivery. The Group provides integrated care management and decision support informationsolutions to clinical professionals in all health care sectors, including:Electronic Health Record solutions (EHR/EPR); Emergency and Minor Injuriesunits; Mental Health and Community units; General Practice surgeries; CommunityRetail Pharmacies; solutions for Patient Administration Systems (PAS) in thecommunity and hospitals; Electronic Prescribing & Medicine Administration(ePMA), Medical Equipment Management and Pharmacy departments. The Group floated on AIM in 2004. Turnover for the year ended 30 June 2006 wasΒ£9.9m with an adjusted operating profit of Β£2.2m. Ascribe currently employs 200 personnel through its seven operating companies inthe UK, Hong Kong, Kenya, Australia and New Zealand. For more information, please visit: www.ascribe.com (c) Ascribe 2006. All trademarks are the property of their respective copyright holders This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20219:49 amRNSUpdate on TIDM Code
1st Jun 20217:00 amRNSAdmission to Main Market
27th Jan 200911:45 amRNSPosting of re-registration circular
21st Jan 20097:30 amRNSOffer Unconditional in all Respects
8th Jan 20097:00 amRNSOffer update
7th Jan 20091:14 pmRNSHolding(s) in Company
5th Jan 20096:08 pmRNSGeneral Meeting & Recommended Cash Offer
18th Dec 20083:55 pmRNSAnnual Report and Accounts
17th Dec 20088:00 amRNSRecommended Cash Offer
10th Dec 200812:42 pmRNSResult of AGM
17th Nov 20087:00 amRNSDirector/PDMR Shareholding
10th Oct 200810:45 amRNSRule 8.3- Ascribe PLC
3rd Oct 200812:09 pmRNSRule 8.3- Ascribe PLC
1st Oct 20087:00 amRNSFinal Results
26th Sep 20087:00 amRNSAcquisition
3rd Sep 20089:06 amRNSExercise of Options
21st Aug 200811:39 amRNSRule 8.3- Ascribe Plc
19th Aug 20088:19 amRNSAnnouncement regarding possib
22nd Jul 20087:00 amRNSTrading Update
8th May 20087:01 amRNSASCC Framework Agreement
14th Apr 20084:29 pmRNSHolding(s) in Company
2nd Apr 20088:00 amRNSInstallement of Web Pharmacy
12th Mar 20087:01 amRNSInterim Results
15th Feb 20082:55 pmRNSIssue of Equity
4th Feb 20089:57 amRNSIssue of Equity
23rd Jan 20087:01 amRNSTrading Statement
21st Jan 20084:54 pmRNSIssue of Equity
7th Dec 200711:23 amRNSHolding(s) in Company
6th Dec 20075:28 pmRNSHolding(s) in Company
29th Nov 200711:29 amRNSDirector/PDMR Shareholding
31st Oct 200711:23 amRNSTrading update &Result of AGM
29th Oct 20073:24 pmRNSHolding(s) in Company
26th Oct 200711:29 amRNSHolding(s) in Company
25th Oct 20074:06 pmRNSDirector/PDMR Shareholding
25th Oct 200711:31 amRNSIssue of Equity
22nd Oct 20071:35 pmRNSIssue of Equity
22nd Oct 200712:40 pmRNSAcquisition
5th Oct 20079:09 amRNSHolding(s) in Company
25th Sep 20072:50 pmRNSHolding(s) in Company
19th Sep 20077:01 amRNSFinal Results
4th Sep 20077:00 amRNSNotice of Results
17th Aug 20075:30 pmRNSAIM Rule 26
17th Aug 20074:53 pmRNSAIM Rule 26 Information
15th Aug 20072:00 pmRNSHolding(s) in Company
9th Aug 20075:57 pmRNSHolding(s) in Company
30th Jul 20072:40 pmRNSIssue of Equity
24th Jul 20077:00 amRNSTrading Update
16th Jul 20075:19 pmRNSHolding(s) in Company
16th Jul 20077:00 amRNSDirectorate Change
8th Jun 20072:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.